Pre-Conference Workshop Day

8:30 am Registration Opens

Workshop A

9:00 am Design Principles of Covalent Fragment Libraries

  • Michael Shaghafi Associate Director of Innovation & Discovery Chemistry, Frontier Medicines

Workshop B

9:00 am Patient Selection & Stratification in RAS Targeted Therapeutics Clinical Trials

  • Bhakti Mehta Executive Medical Director, Hematology Oncology Global Development, Amgen Inc.
  • Rajwanth Veluswamy Assistant Professor, Onconova Therapeutics Inc

11:00 am Morning Break

Workshop C

12:00 pm Targeted Delivery of Anti-RAS Therapeutics

  • Andrew Whale Associate Director, Pipeline Biology, Immunocore Ltd

Workshop D

12:00 pm Benchmarking Animal Models & Systems Being Used to Compare Therapeutic Efficacy & Translation

  • Andrew Aguirre Physician Scientist & Medical Oncologist, Dana-Farber Cancer Institute

Workshop E

12:00 pm Implementing Intermittent Dosing Schedules for Anti-RAS Therapeutics

  • Mark Gelder Chief Medical Officer, Onconova Therapeutics Inc

2:00 pm Afternoon Networking Break

Workshop F

3:00 pm Intrinsic & Adaptive Resistance

Workshop G

3:00 pm The RASopathies – The Evolving Field & Mechanistic Understanding

  • Nancy Ratner Co-Leader, Rasopathy Program, Professor of Pediatrics, Cincinnati Childrens Hospital Medical Center
  • Pau Castel Assistant Professor, Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, NYU Perlmutter Cancer Center

Workshop H

3:00 pm Reviewing Targeted Therapies Against GI Cancers – What is Next?

  • Richard Kim Service Chief of Medical Gastrointestinal Oncology, Moffitt Cancer Center

5:00 pm End of Pre-Conference Workshop Day